Clinically, elevated levels of both LDHA and NUDT21, as well as increased K23-lactylated NUDT21, are associated with reduced FDX1 expression and worse prognosis in ESCC patients. This evidence concerns the gene FDX1 and esophageal squamous cell carcinoma.